Summary of the 2023 international evidence‐based guideline for the assessment and management of polycystic ovary syndrome: an Australian perspective
The 2023 guideline is approved by the National Health and Medical Research Council and provides clinicians and patients with clear advice on best practice in a common and neglected condition, based on the best available evidence, expert multidisciplinary input and consumer preferences. It provides vital, extensive patient and provider resources to enhance evidence-based care. The full guideline is available at www.monash.edu/medicine/mchri/pcos/guideline.
Authors
- Jacqueline Boyle (ORCID: https://orcid.org/0000-0002-3616-1637)
- Alexia Peña (ORCID: https://orcid.org/0000-0002-6834-4876)
- Chau Thien Tay (ORCID: https://orcid.org/0000-0001-6228-2654)
- Lisa Moran (ORCID: https://orcid.org/0000-0001-5772-6484)
- Helena Jane Teede (ORCID: https://orcid.org/0000-0001-7609-577X)
- Robert J. Norman (ORCID: https://orcid.org/0000-0002-3118-3896)
- Aya Mousa (ORCID: https://orcid.org/0000-0002-7356-4523)
- Michael Costello (ORCID: https://orcid.org/0000-0001-7340-1356)
- Anju E. Joham (ORCID: https://orcid.org/0000-0002-6307-2568)
- Leah Brennan (ORCID: https://orcid.org/0000-0002-9180-5888)
- Lorna Berry
Institutions
- La Trobe University (AU)
- Royal Hospital for Women (AU)
- UNSW Sydney (AU)
- Monash IVF (AU)
- Calvary Hospital (AU)
- Monash University (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- The Medical Journal of Australia
- Published
- 2024-09-02
- DOI
- https://doi.org/10.5694/mja2.52432
- Citations
- 12
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 6.44
Funders
- Medical Research Council
- National Health and Medical Research Council